Key Metrics
3.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.85
5-Year SI
5-year SI
- N/A 2-year SI
- 0.85 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q4
Pharmacology
SJR
- Q3 Pharmacology
- Q4 Cancer Research
- Q3 Biochemistry, Genetics and Molecular Biology (all)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.84
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Overall survival
- Amino acid
- Lung cancer
- Sarcopenia
- Lymph node
- Neurofibromatosis
- Chemoradiotherapy
- Genotype
- Hepatocellular carcinoma
- Cerebral cortex
- Breast cancer
- Irradiation
- Partial response
- Thrombotic microangiopathy
- Lung
- Surgery
- Reactive oxygen species
- Adjuvant
- Osteoid osteoma
Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1987 |
| Website URL | Visit website |
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer
- 1 Jan 22
- In Vivo
-
Full paper
Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
- 1 Jan 22
- In Vivo
-
Full paper
Medicinal Plants Used for Abdominal Discomfort – Information from Cancer Patients and Medical Students
- 1 Jan 22
- In Vivo
-
Full paper
Error Detectability of Isodose Volumes as ROIs in Prostate Intensity-modulated RT QA
- 1 Jan 22
- In Vivo
-
Full paper
Immunostimulation and Coagulopathy in COVID-19 Compared to Patients With H1N1 Pneumonia or Bacterial Sepsis
- 1 Jan 22
- In Vivo
-
Full paper
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract
- 1 Jan 22
- In Vivo
Scite analysis
Powered by scite_
2.6k articles received 13.2k citations see all
- 537 Supporting
- 12,202 Mentioning
- 92 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has In Vivo been actively publishing?
In Vivo has been in operation since 1987 till date.
What is the publishing frequency of In Vivo ?
In Vivo published with a Bi-monthly frequency.
How many articles did In Vivo publish last years ?
In 2023, In Vivo published articles.
What is the eISSN & pISSN for In Vivo ?
For In Vivo,eISSN is 1791-7549 and pISSN is0258-851X.
What is Citescore for In Vivo ?
Citescore for In Vivo is 3.1.
What is SNIP score for In Vivo ?
SNIP score for In Vivo is 0.84.
What is the SJR for In Vivo ?
SJR for In Vivo is Q4.
Who is the publisher of In Vivo ?
INT INST ANTICANCER RESEARCH is the publisher of In Vivo.